154 related articles for article (PubMed ID: 19649725)
1. Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells.
Wang L; Xue L; Yan H; Li J; Lu Y
Mol Biol Rep; 2010 Apr; 37(4):1971-7. PubMed ID: 19649725
[TBL] [Abstract][Full Text] [Related]
2. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966
[TBL] [Abstract][Full Text] [Related]
3. Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1.
Liu Z; Yu J; Wu R; Tang S; Cai X; Guo G; Chen S
Med Sci Monit; 2017 Dec; 23():6174-6185. PubMed ID: 29288243
[TBL] [Abstract][Full Text] [Related]
4. Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cells.
Wang L; Hou G; Xue L; Li J; Wei P; Xu P
Cancer Invest; 2010 Dec; 28(10):993-1003. PubMed ID: 20504226
[TBL] [Abstract][Full Text] [Related]
5. ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma.
Wang ZM; Yang DS; Liu J; Liu HB; Ye M; Zhang YF
Tumour Biol; 2016 Mar; 37(3):3757-64. PubMed ID: 26468018
[TBL] [Abstract][Full Text] [Related]
6. A Rho-associated coiled-coil containing kinases (ROCK) inhibitor, Y-27632, enhances adhesion, viability and differentiation of human term placenta-derived trophoblasts in vitro.
Motomura K; Okada N; Morita H; Hara M; Tamari M; Orimo K; Matsuda G; Imadome KI; Matsuda A; Nagamatsu T; Fujieda M; Sago H; Saito H; Matsumoto K
PLoS One; 2017; 12(5):e0177994. PubMed ID: 28542501
[TBL] [Abstract][Full Text] [Related]
7. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
[TBL] [Abstract][Full Text] [Related]
8. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration.
Ortíz-López L; Morales-Mulia S; Ramírez-Rodríguez G; Benítez-King G
J Pineal Res; 2009 Jan; 46(1):15-21. PubMed ID: 18482340
[TBL] [Abstract][Full Text] [Related]
9. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells.
Bhandary L; Whipple RA; Vitolo MI; Charpentier MS; Boggs AE; Chakrabarti KR; Thompson KN; Martin SS
Oncotarget; 2015 Mar; 6(8):6251-66. PubMed ID: 25749040
[TBL] [Abstract][Full Text] [Related]
10. Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.
Imamura F; Mukai M; Ayaki M; Akedo H
Jpn J Cancer Res; 2000 Aug; 91(8):811-6. PubMed ID: 10965022
[TBL] [Abstract][Full Text] [Related]
11. Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner.
Lawler K; Foran E; O'Sullivan G; Long A; Kenny D
Am J Physiol Cell Physiol; 2006 Oct; 291(4):C668-77. PubMed ID: 16641163
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
[TBL] [Abstract][Full Text] [Related]
13. Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells.
Koga T; Koga T; Awai M; Tsutsui J; Yue BY; Tanihara H
Exp Eye Res; 2006 Mar; 82(3):362-70. PubMed ID: 16125171
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase inhibitor upregulates migration by altering focal adhesion formation via the Akt pathway in colon cancer cells.
Adachi S; Yasuda I; Nakashima M; Yamauchi T; Yoshioka T; Okano Y; Moriwaki H; Kozawa O
Eur J Pharmacol; 2011 Jan; 650(1):145-50. PubMed ID: 20959118
[TBL] [Abstract][Full Text] [Related]
15. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity.
Gao S; Li S; Duan X; Gu Z; Ma Z; Yuan X; Feng X; Wang H
Mol Carcinog; 2017 Oct; 56(10):2301-2316. PubMed ID: 28574599
[TBL] [Abstract][Full Text] [Related]
17. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
18. Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.
Chen L; Pan J
Br J Pharmacol; 2017 Aug; 174(15):2427-2443. PubMed ID: 28444744
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
[TBL] [Abstract][Full Text] [Related]
20. Interaction between mDia1 and ROCK in Rho-induced migration and adhesion of human dental pulp cells.
Cheng L; Xu J; Qian YY; Pan HY; Yang H; Shao MY; Cheng R; Hu T
Int Endod J; 2017 Jan; 50(1):15-23. PubMed ID: 26609804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
